annual ROE:
-19.20%-11.03%(-135.01%)Summary
- As of today (June 29, 2025), CRSP annual return on equity is -19.20%, with the most recent change of -11.03% (-135.01%) on December 31, 2024.
- During the last 3 years, CRSP annual ROE has fallen by -37.79% (-203.28%).
- CRSP annual ROE is now -120.09% below its all-time high of 95.55%, reached on December 31, 2014.
Performance
CRSP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-20.08%-1.43%(-7.67%)Summary
- As of today (June 29, 2025), CRSP quarterly return on equity is -20.08%, with the most recent change of -1.43% (-7.67%) on March 31, 2025.
- Over the past year, CRSP quarterly ROE has dropped by -8.49% (-73.25%).
- CRSP quarterly ROE is now -121.58% below its all-time high of 93.07%, reached on March 31, 2016.
Performance
CRSP quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CRSP ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -135.0% | -73.3% |
| 3 y3 years | -203.3% | -249.1% |
| 5 y5 years | -291.2% | -379.3% |
CRSP ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -203.3% | +36.9% | -249.1% | +34.7% |
| 5 y | 5-year | -203.3% | +36.9% | -174.9% | +34.7% |
| alltime | all time | -120.1% | +66.3% | -121.6% | +94.4% |
CRSP ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | -20.08%(+7.7%) |
| Dec 2024 | -19.20%(+135.0%) | -18.65%(+49.7%) |
| Sep 2024 | - | -12.46%(-11.0%) |
| Jun 2024 | - | -14.00%(+20.8%) |
| Mar 2024 | - | -11.59%(+38.1%) |
| Dec 2023 | -8.17%(-73.1%) | -8.39%(-56.2%) |
| Sep 2023 | - | -19.16%(-11.6%) |
| Jun 2023 | - | -21.68%(-17.1%) |
| Mar 2023 | - | -26.15%(-15.0%) |
| Dec 2022 | -30.42%(-263.6%) | -30.77%(+1.3%) |
| Sep 2022 | - | -30.39%(+13.7%) |
| Jun 2022 | - | -26.72%(-298.4%) |
| Mar 2022 | - | 13.47%(-21.6%) |
| Dec 2021 | 18.59%(-169.4%) | 17.19%(-17.1%) |
| Sep 2021 | - | 20.74%(-22.6%) |
| Jun 2021 | - | 26.81%(-190.3%) |
| Mar 2021 | - | -29.68%(-2.3%) |
| Dec 2020 | -26.80% | -30.37%(+34.3%) |
| Sep 2020 | - | -22.61%(-953.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | 2.65%(-63.1%) |
| Mar 2020 | - | 7.19%(-42.6%) |
| Dec 2019 | 10.04%(-117.6%) | 12.52%(-577.9%) |
| Sep 2019 | - | -2.62%(-95.2%) |
| Jun 2019 | - | -54.99%(+3.7%) |
| Mar 2019 | - | -53.04%(-0.2%) |
| Dec 2018 | -56.89%(+75.0%) | -53.12%(+21.4%) |
| Sep 2018 | - | -43.76%(+7.4%) |
| Jun 2018 | - | -40.73%(+15.9%) |
| Mar 2018 | - | -35.13%(+4.1%) |
| Dec 2017 | -32.50%(+42.7%) | -33.75%(+0.1%) |
| Sep 2017 | - | -33.72%(+17.1%) |
| Jun 2017 | - | -28.79%(-21.9%) |
| Mar 2017 | - | -36.85%(+9.8%) |
| Dec 2016 | -22.78%(-125.7%) | -33.56%(-90.7%) |
| Sep 2016 | - | -361.13%(+333.6%) |
| Jun 2016 | - | -83.29%(-189.5%) |
| Mar 2016 | - | 93.07%(+45.3%) |
| Dec 2015 | 88.77%(-7.1%) | 64.06% |
| Dec 2014 | 95.55% | - |
FAQ
- What is CRISPR Therapeutics AG annual return on equity?
- What is the all time high annual ROE for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual ROE year-on-year change?
- What is CRISPR Therapeutics AG quarterly return on equity?
- What is the all time high quarterly ROE for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly ROE year-on-year change?
What is CRISPR Therapeutics AG annual return on equity?
The current annual ROE of CRSP is -19.20%
What is the all time high annual ROE for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual return on equity is 95.55%
What is CRISPR Therapeutics AG annual ROE year-on-year change?
Over the past year, CRSP annual return on equity has changed by -11.03% (-135.01%)
What is CRISPR Therapeutics AG quarterly return on equity?
The current quarterly ROE of CRSP is -20.08%
What is the all time high quarterly ROE for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly return on equity is 93.07%
What is CRISPR Therapeutics AG quarterly ROE year-on-year change?
Over the past year, CRSP quarterly return on equity has changed by -8.49% (-73.25%)